Your browser doesn't support javascript.
loading
Omalizumab therapy for refractory allergic fungal rhinosinusitis patients with moderate or severe asthma.
Gan, Eng Cern; Habib, Al-Rahim R; Rajwani, Alykhan; Javer, Amin R.
Afiliação
  • Gan EC; Division of Otolaryngology, University of British Columbia, St. Paul's Sinus Centre, 1081 Burrard St., Vancouver, British Columbia, Canada; Department of Otolaryngology-Head & Neck Surgery, Changi General Hospital, 2 Simei Street 3, Singapore. Electronic address: engcern@gmail.com.
  • Habib AR; Division of Otolaryngology, University of British Columbia, St. Paul's Sinus Centre, 1081 Burrard St., Vancouver, British Columbia, Canada.
  • Rajwani A; Division of Otolaryngology, University of British Columbia, St. Paul's Sinus Centre, 1081 Burrard St., Vancouver, British Columbia, Canada.
  • Javer AR; Division of Otolaryngology, University of British Columbia, St. Paul's Sinus Centre, 1081 Burrard St., Vancouver, British Columbia, Canada.
Am J Otolaryngol ; 36(5): 672-7, 2015.
Article em En | MEDLINE | ID: mdl-26117492
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Sinusite / Rinite Alérgica / Omalizumab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Sinusite / Rinite Alérgica / Omalizumab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article